Advancements in the study of glucose metabolism in relation to tumor progression and treatment

M Zhao, Y Chen, LH Yang - Progress in Biophysics and Molecular Biology, 2024 - Elsevier
Sugar serves as the primary energy source for mammals, with glucose metabolism
facilitating energy acquisition in human cells. The proper functioning of intracellular glucose …

From mechanism to therapy: the journey of CD24 in cancer

K Zhao, C Wu, X Li, M Niu, D Wu, X Cui… - Frontiers in …, 2024 - frontiersin.org
CD24 is a glycosylphosphatidylinositol-anchored protein that is expressed in a wide range
of tissues and cell types. It is involved in a variety of physiological and pathological …

Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids

M Cioce, MR Fumagalli, S Donzelli, F Goeman… - Journal of Experimental …, 2023 - Springer
Abstract Background Approximately 20–50% of patients presenting with localized colorectal
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …

Novel function of cancer stem cell marker ALDH1A3 in glioblastoma: pro-angiogenesis through paracrine PAI-1 and IL-8

Z Chen, R Will, SN Kim, MA Busch, N Dünker… - Cancers, 2023 - mdpi.com
Simple Summary Hyper-angiogenesis is a characteristic of glioblastoma (GBM), and anti-
angio-genesis is a crucial strategy to interfere with tumor progression in GBM therapy. We …

Enhanced sensitivity to aldh1a3-dependent ferroptosis in TMZ-resistant glioblastoma cells

Y Wu, S Franzmeier, F Liesche-Starnecker, J Schlegel - Cells, 2023 - mdpi.com
Temozolomide (TMZ) is standard treatment for glioblastoma (GBM); nonetheless, resistance
and tumor recurrence are still major problems. In addition to its association with recurrent …

Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor

K Gowda, A Raza, V Vangala, NA Lone, JM Lin… - Molecules, 2024 - mdpi.com
Aldehyde dehydrogenases (ALDHs) are a family of enzymes that aid in detoxification and
are overexpressed in several different malignancies. There is a correlation between …

A selective ALDH1A3 inhibitor impairs mesothelioma 3-d multicellular spheroid growth and neutrophil recruitment

S Boumya, S Fallarini, S Siragusa, G Petrarolo… - International Journal of …, 2023 - mdpi.com
Aldehyde dehydrogenase 1A3 (ALDH1A3), one of the three members of the aldehyde
dehydrogenase 1A subfamily, has been associated with increased progression and drug …

Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer

J Lee, T Mashima, N Kawata, N Yamamoto… - Cancer Research …, 2024 - AACR
Anticancer drug-tolerant persister (DTP) cells at an early phase of chemotherapy reshape
refractory tumors. Aldehyde dehydrogenase 1 family member A3 (ALDH1A3) is commonly …

Oncogene activated human breast luminal progenitors contribute basally located myoepithelial cells

KT Kohler, J Kim, R Villadsen, L Rønnov-Jessen… - Breast Cancer …, 2024 - Springer
Background Basal-like breast cancer originates in luminal progenitors, frequently with an
altered PI3K pathway, and focally in close association with genetically altered myoepithelial …

Vitamin A Metabolism and Resistance of Hepatic Metastases to Immunotherapy

PC Jones, DD Von Hoff - Molecular cancer therapeutics, 2024 - aacrjournals.org
The liver is an immune-tolerant organ, allowing for organ transplantation with less immune
suppression compared with other organs. It also provides fertile soil for tumor metastases …